MEHCQ — Chrome Holding Co Share News
0.000.00%
Last trade - 00:00- $96.60m
- $81.77m
- $189.90m
23andMe's unit to offer GLP-1 medication through weight loss program, shares rise
Brief: Lemonaid Health Now Offering Glp-1 Medication Through Weight Loss Membership Program
23andMe Holding Co. reports results for the quarter ended in June - Earnings Summary
Brief: 23andMe Q1 Revenue USD 40 Million
23andMe rejects CEO Wojcicki take-private offer (updated)
23andMe says disappointed with CEO's Wojcicki take-private offer
23andMe CEO Wojcicki makes offer to take the firm private, filing shows
Canada, UK launched joint probe into 23andMe data breach, says Canada
23andMe Holding Co. reports results for the quarter ended in January - Earnings Summary
Brief: 23andMe Q4 Revenue USD 64 Million
23andMe Holding Co. expected to post a loss of 15 cents a share - Earnings Preview
Brief: 23andMe Holding Granted Additional 180 Days, Or Until Nov 4 To Regain Compliance With Minimum Bid Price Requirement For Continued Listing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Genetic testing firm 23andMe rises after CEO considers taking firm private
U.S. STOCKS ON THE MOVE-D.R. Horton, 23andMe, Copper miners
Genetic testing firm 23andMe extends gains after CEO considers taking firm private
Brief: 23AndMe Announces CEO’s Intention To Pursue A Potential Take-Private
23andMe rises after CEO considers taking firm private
Press Digest: Wall Street Journal - April 18